Back to Drug Development
University of California San Diego

Drug Development

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place.

Status: Clinical Trials
Status: Regulatory Affairs
BeginnerCourse10 hours

Featured reviews

SJ

4.0Reviewed Jul 31, 2020

It is really informative and nice to learn about such a vast and growing industry. The only complain I have is all the data was from 2012 which has now either been changed or updated.

SK

5.0Reviewed May 24, 2020

I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process. Thank you!

SC

4.0Reviewed Jun 1, 2021

T​he course should be updated. Most of the data presented is almost a decade old. Also, The person who teaches about Phase II trails is not clear, and it is hard to understand him.

NV

5.0Reviewed Sep 25, 2019

Thank you very much for covering all Phases of clinical trial. Very useful and informative. Thank you for providing me with the financial aid to complete this course.

MT

5.0Reviewed Jun 8, 2020

Clinical trial are most important part of pharma sector for drug development and development of a molecule It's important to all of us whose involved in research and development Thank you!!!

SO

5.0Reviewed Jun 15, 2019

Great course for learning the basics of the drug development process from clinical trials to filling marketing and post-marketing commitments. Great place to start!

VP

4.0Reviewed Apr 28, 2021

The course was informative and found exactly at the time of need. I was a little disappointed because it's not the latest updated version. looking forward to the updated version of the course.

MR

5.0Reviewed Jul 18, 2018

Information in the course is very practical. I come from basic biology background and now with this course I gained some real insights about how the clinical trails happen.

HD

5.0Reviewed Aug 2, 2020

Great introduction to the nuances of drug development, post research and into clinical and commercial aspects. I feel much more ready to enter the regulatory affairs arena after this.

PR

5.0Reviewed Dec 1, 2018

Fantastic course, learned a lot of new things. Will go for the drug discovery course next. Consider including the presentations before the tests rather than afterwards

NP

5.0Reviewed Dec 30, 2021

Comprehensive review of all phases of drug development from IND to NDA and post-approval.. thoroughly enjoyed the lectures on phase I & II study design and interpretation!

MS

4.0Reviewed Jul 13, 2020

I would have loved to have a specific case study to follow as an example of how a drug goes through the whole life cycle as the course felt a bit too high-level overview at times.

All reviews

Showing: 20 of 486

Ekaterine Bakhtadze-Bagci
1.0
Reviewed Feb 20, 2018
Cynthia Veenstra
2.0
Reviewed Jan 28, 2020
shaurya bajwa
5.0
Reviewed Jan 23, 2019
Deleted Account
3.0
Reviewed Feb 26, 2018
Dr.V.Padmavathi
5.0
Reviewed Jul 4, 2020
Jesse Gonzalez
5.0
Reviewed Jan 18, 2021
Miriam Chidam
4.0
Reviewed May 8, 2019
Adrián Posado Fernández
3.0
Reviewed Nov 12, 2018
Philip Riedel
5.0
Reviewed Dec 2, 2018
Emily Kitts
5.0
Reviewed Jan 23, 2020
Dr. Harish Ravi
5.0
Reviewed Aug 29, 2018
Michael Doyle
5.0
Reviewed Sep 2, 2018
Antonios Marios Chionis
5.0
Reviewed Jun 3, 2018
HASAN BILLAH
5.0
Reviewed Mar 8, 2020
Heather Grace
5.0
Reviewed Oct 16, 2018
ELENA FERNÁNDEZ DELGADO
2.0
Reviewed Apr 29, 2020
Yurshanva Kasar
1.0
Reviewed Sep 3, 2019
Shyam Pahurkar
5.0
Reviewed Sep 14, 2019
Giridhar Rao Gutlapalli
5.0
Reviewed May 2, 2020
Ahmed Ibrahim Ismail
5.0
Reviewed Dec 30, 2019